Frequentist rules for regulatory approval of subgroups in phase III trials: A fresh look at an old problem.

Edgar, K; Jackson, D; Rhodes, K; Duffy, T; Burman, C-F; Sharples, LD; (2021) Frequentist rules for regulatory approval of subgroups in phase III trials: A fresh look at an old problem. Statistical Methods in Medical Research, 30 (7). pp. 1725-1743. ISSN 0962-2802 DOI: https://doi.org/10.1177/09622802211017574

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1177/09622802211017574

Abstract

Item Type Article
Faculty and Department Faculty of Epidemiology and Population Health > Dept of Medical Statistics
Research Centre Clinical Trials Unit
PubMed ID 34077288
Elements ID 158854

Share

Download

Filename: Edgar_etal_2021_Frequentist-rules-for-regulatory-approval.pdf

Licence: Creative Commons: Attribution 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar